Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Coleman

Showing results (191-200 of 510) with videos related to

Pageof 51
Sort By:
Molecular Psychiatry|July 22, 2021
Exploring the genetic heterogeneity in major depression across diagnostic criteriaBradley S Jermy, Kylie P Glanville, Jonathan R I Coleman, et al.
Current Medical Research and Opinion|April 20, 2018
The impact of non-medical switch on type 2 diabetes patients treated with canagliflozin in the commercially insured US populationLawrence Blonde, Chakkarin Burudpakdee, Victoria Divino, et al.
Atherosclerosis|June 7, 2019
Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient SampleChristine G Kohn, Mark J Alberts, W Frank Peacock, et al.
Current Medical Research and Opinion|March 21, 2012
Effect of dosing frequency on chronic cardiovascular disease medication adherenceCraig I Coleman, Matthew S Roberts, Diana M Sobieraj, et al.
Clinical Therapeutics|March 2, 2006
A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgeryEffie L Gillespie, C Michael White, Jeffrey Kluger, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 9, 2018
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous ThromboembolismCraig I Coleman, Jan Beyer-Westendorf, Thomas J Bunz, et al.
Thrombosis Journal|April 16, 2020
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysisOlivia S Costa, Stanley Thompson, Veronica Ashton, et al.
Briefings in Functional Genomics|October 8, 2015
Quality control, imputation and analysis of genome-wide genotyping data from the Illumina HumanCoreExome microarrayJonathan R I Coleman, Jack Euesden, Hamel Patel, et al.
Chest|October 16, 2014
Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysisChristine G Kohn, Elizabeth S Mearns, Matthew W Parker, et al.
Biological Psychiatry Global Open Science|July 19, 2021
Investigating Pleiotropy Between Depression and Autoimmune Diseases Using the UK BiobankKylie P Glanville, Jonathan R I Coleman, Paul F O'Reilly, et al.
Pageof 51

Showing results (191-200 of 510) with videos related to

Sort By:
Pageof 51
Molecular Psychiatry|July 22, 2021
Exploring the genetic heterogeneity in major depression across diagnostic criteriaBradley S Jermy, Kylie P Glanville, Jonathan R I Coleman, et al.
Current Medical Research and Opinion|April 20, 2018
The impact of non-medical switch on type 2 diabetes patients treated with canagliflozin in the commercially insured US populationLawrence Blonde, Chakkarin Burudpakdee, Victoria Divino, et al.
Atherosclerosis|June 7, 2019
Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient SampleChristine G Kohn, Mark J Alberts, W Frank Peacock, et al.
Current Medical Research and Opinion|March 21, 2012
Effect of dosing frequency on chronic cardiovascular disease medication adherenceCraig I Coleman, Matthew S Roberts, Diana M Sobieraj, et al.
Clinical Therapeutics|March 2, 2006
A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgeryEffie L Gillespie, C Michael White, Jeffrey Kluger, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 9, 2018
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous ThromboembolismCraig I Coleman, Jan Beyer-Westendorf, Thomas J Bunz, et al.
Thrombosis Journal|April 16, 2020
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysisOlivia S Costa, Stanley Thompson, Veronica Ashton, et al.
Briefings in Functional Genomics|October 8, 2015
Quality control, imputation and analysis of genome-wide genotyping data from the Illumina HumanCoreExome microarrayJonathan R I Coleman, Jack Euesden, Hamel Patel, et al.
Chest|October 16, 2014
Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysisChristine G Kohn, Elizabeth S Mearns, Matthew W Parker, et al.
Biological Psychiatry Global Open Science|July 19, 2021
Investigating Pleiotropy Between Depression and Autoimmune Diseases Using the UK BiobankKylie P Glanville, Jonathan R I Coleman, Paul F O'Reilly, et al.
Pageof 51